SCHEMBL386910

SCHEMBL386910

CC(C)(C)OC(=O)n1cccc1CI.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
BCHE P06276 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
ABCB1 P08183 1/20 0.34
HTR6 P50406 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
AKT1 P31749 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
EPHX1 P07099 1/20 0.34
TNK2 Q07912 1/20 0.34
NR1H2 P55055 2/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
NR1H3 Q13133 1/20 0.33
BUB1 O43683 1/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL445392 0.79 HSP90AA1 (0.44) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL2628927 0.76 HSP90AA1 (0.44) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL445394 0.76 HSP90AA1 (0.44) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL19974442 0.75 HSP90AA1 (0.49) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL14949338 0.74 HSP90AA1 (0.42) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
Iodide SCHEMBL386911 0.73 BCHE (0.39) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL23303726 0.72 HSP90AA1 (0.41) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL8293842 0.72 HSP90AA1 (0.42) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1
SCHEMBL4791995 0.72 NAMPT (0.51) GPR119CHRM2CHRM4CHRM1CHRM3
SCHEMBL6951565 0.70 HSP90AA1 (0.40) L3MBTL1BCHEHSP90AA1HSP90AB1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101650-B2 Method for treating a immunology-related disease DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-24 US disclosed
US-8067396-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2011-11-29 US disclosed
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2010-02-11 US disclosed
US-20090326038-A1 Method for treating a immunology-related disease SANKYO COMPANY, LIMITED (JP) 2009-12-31 US disclosed
US-7638551-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2009-12-29 US disclosed
EP-1471054-B1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE DAIICHI SANKYO CO LTD (JP) 2009-07-01 EP disclosed
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2007-06-21 US disclosed
US-20070105933-A1 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-05-10 US disclosed
US-7199150-B2 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these SANKYO COMPANY, LIMITED (JP) 2005-02-24 US disclosed
EP-1471054-A1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE Sankyo Company, Limited (JP) 2004-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these PHOSPHO1, CD4, FCGRT L3MBTL1 3349/4885BCHE 2350/4885HSP90AA1 2575/4885
US-20090326038-A1 Method for treating a immunology-related disease C3AR1, HRH3, HRH2 L3MBTL1 542/4885BCHE 359/4885HSP90AA1 3297/4885
US-20070105933-A1 Amino alcohol compounds ADH1C, C9, SSB L3MBTL1 909/4885BCHE 2962/4885HSP90AA1 3581/4885
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof HRH3, C3AR1, HRH4 L3MBTL1 1922/4885BCHE 2674/4885HSP90AA1 2844/4885
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof PHOSPHO1, ADH1C, ADH1A L3MBTL1 2079/4885BCHE 2253/4885HSP90AA1 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.